Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Malignant Lymphoma

Free Subscription 12.01.2026 5 Blood 2 Bone Marrow Transplant 1 Br J Haematol 2 Cancer 1 Cancer Lett 1 Eur J Haematol 1 Haematologica 2 J Clin Oncol 4 Leuk Lymphoma 1 Mol Ther Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Blood

1. ARMAND P
   Introduction to a review series on marginal zone lymphoma: reclaiming the afterthought.
   Blood. 2026;147:95.
   PubMed        
   
   
2. ALDERUCCIO JP, Baggio D, Han S, Ghione P, et al
   Treatment-related Outcomes and Patterns of Relapse in Secondary CNS Involvement by Large B-cell Lymphoma.
   Blood. 2026 Jan 5:blood.2025031455. doi: 10.1182/blood.2025031455.
   PubMed         Abstract available
   
   
3. WIEGAND L, Silva P, Noerenberg D, Christen F, et al
   Clonal Hematopoiesis and Lymphoma-Associated Mutations in Hematopoietic Progenitors in B-Cell Non-Hodgkin Lymphoma.
   Blood. 2026 Jan 5:blood.2025030489. doi: 10.1182/blood.2025030489.
   PubMed         Abstract available
   
   
4. LUAN D, Valid OB, Beyar-Katz O, Tix T, et al
   Time of Day of CAR T-Cell Infusion and Outcomes in Large B-Cell Lymphoma.
   Blood. 2025 Dec 23:blood.2025031476. doi: 10.1182/blood.2025031476.
   PubMed         Abstract available
   
   
5. LAURENT C, Bertoni F
   The biology of marginal zone lymphoma subtypes: challenge and relevance of classification.
   Blood. 2026;147:105-114.
   PubMed         Abstract available
   
   

   
   Bone Marrow Transplant

6. CANELO-VILASECA M, Sabbah M, Cristinelli C, Come B, et al
   Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?
   Bone Marrow Transplant. 2026 Jan 8. doi: 10.1038/s41409-025-02754.
   PubMed        
   
   
7. LOPEZ-PEREIRA P, Bazarbachi A, Marcais A, Ngoya M, et al
   Outcomes of patients with HTLV-1 adult T-cell leukemia/lymphoma (ATLL) after allogeneic SCT: results of the EBMT LWP.
   Bone Marrow Transplant. 2026 Jan 3. doi: 10.1038/s41409-025-02783.
   PubMed         Abstract available
   
   

   
   Br J Haematol

8. UENO T, Yoshimitsu M, Sameshima M, Nagano T, et al
   Clinical features and incidence of central nervous system involvement in patients with adult T-cell leukaemia/lymphoma.
   Br J Haematol. 2026 Jan 5. doi: 10.1111/bjh.70301.
   PubMed         Abstract available
   
   

   
   Cancer

9. KONOPLEVA M, Pemmaraju N, Sweet KL, Stein AS, et al
   Hematopoietic effects of tagraxofusp in treatment-naive patients with blastic plasmacytoid dendritic cell neoplasm.
   Cancer. 2026;132:e70243.
   PubMed         Abstract available
   
   
10. ZHAO W, Li L, Fu X, Chang Y, et al
    A first-line regimen combining Bruton's tyrosine kinase and programmed cell death protein-1 inhibitors with chemotherapy excluding methotrexate achieves high response rates in primary central nervous system lymphoma.
    Cancer. 2026;132:e70247.
    PubMed         Abstract available
    
    

    
    Cancer Lett

11. SHI Q, Zhang M, He Y, Lin R, et al
    Baseline tumor-informed circulating tumor DNA concentration predicts early chemoimmunotherapy failure in diffuse large B-cell lymphoma.
    Cancer Lett. 2026 Jan 7:218249. doi: 10.1016/j.canlet.2026.218249.
    PubMed        
    
    

    
    Eur J Haematol

12. BERNARDELLI A, Carazzai E, Bugnotto B, Bellinato F, et al
    Primary Cutaneous B-Cell Lymphomas: An Updated Portrait of Classification, Biology, and Clinical Management.
    Eur J Haematol. 2026;116:116-128.
    PubMed         Abstract available
    
    

    
    Haematologica

13. BES AL, Zwezerijnen GJC, Heymans MW, Duhrsen U, et al
    Improving the predictive value of end-of-treatment PET/CT in diffuse large B-cell lymphoma.
    Haematologica. 2026 Jan 8. doi: 10.3324/haematol.2025.288821.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

14. CASTELLINO SM, Li H, Herrera AF, LeBlanc M, et al
    Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826.
    J Clin Oncol. 2026 Jan 9:JCO2500203. doi: 10.1200/JCO-25-00203.
    PubMed         Abstract available
    
    
15. HAYASHI RJ, Winter SS, Dunsmore KP, Devidas M, et al
    Erratum: Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434.
    J Clin Oncol. 2026 Jan 5:JCO2502779. doi: 10.1200/JCO-25-02779.
    PubMed        
    
    

    
    Leuk Lymphoma

16. YU Y, Xiang Z, Hou X, Hu K, et al
    Efficacy and safety of radiotherapy as a bridging strategy to CD19-targeted CAR-T therapy: systematic review and meta-analysis.
    Leuk Lymphoma. 2026;67:123-134.
    PubMed         Abstract available
    
    
17. SAITO Y, Oda T, Nakanishi S, Ota M, et al
    Safety profiles in elderly patients with DLBCL on first-line Pola-R-CHP: a claims database study in Japan.
    Leuk Lymphoma. 2026;67:135-147.
    PubMed         Abstract available
    
    
18. GUO J, Li M, Zhang L, Zhang Q, et al
    Clinical outcomes of modified busulfan plus cyclophosphamide versus total body irradiation plus cyclophosphamide for T-cell acute lymphoblastic leukemia/lymphoma.
    Leuk Lymphoma. 2026 Jan 5:1-14. doi: 10.1080/10428194.2025.2605516.
    PubMed         Abstract available
    
    
19. ABALO KD, Trab T, Baech J, Ekberg S, et al
    Survival in mantle cell lymphoma patients burdened by a second primary malignancy.
    Leuk Lymphoma. 2026 Jan 9:1-11. doi: 10.1080/10428194.2025.2606211.
    PubMed         Abstract available
    
    

    
    Mol Ther Oncol

20. ZHAO R, Xia J, Zheng Y, Huang W, et al
    CAR-T cell exhaustion in B cell lymphoma: Current status, mechanisms, and potential solutions.
    Mol Ther Oncol. 2025;34:201099.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.